The Impact of HBV Therapy on Fibrosis and Cirrhosis

Jordan J. Feld, MD, MPH, illustrates the key data on optimal management of fibrosis and cirrhosis in HBV, including the effect of therapy on fibrosis/cirrhosis regression and HCC and applying the data to clinical practice.
Jordan J. Feld, MD, MPH

Impact of HBV Therapy

In this downloadable slideset, Jordan J. Feld, MD, MPH, illustrates the key data on optimal management of fibrosis and cirrhosis in HBV.

Released: December 22, 2016

In this CME-certified module, Jordan J. Feld, MD, MPH, provides guidance on strategies to reverse liver fibrosis and cirrhosis with oral antiviral agents in patients with chronic hepatitis B.

Jordan J. Feld, MD, MPH Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: December 30, 2016 Expiration: December 29, 2017
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an independent educational grant from
Gilead Sciences

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?